News from saladax biomedical, inc

Mar 20, 2014, 06:05 ET

A Dose of Reality About Chemotherapy Dosing -- Saladax Has The Antidote - My5-FU™

 Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is offering a simple blood test for the personalization and...

Nov 15, 2013, 10:22 ET

Adrienne Choma, Co-Founder of Saladax Biomedical, Named One of National Winners of 2013 EY Entrepreneurial Winning Women™ Program

Today, Adrienne Choma, Esq., Co-Founder, Sr. VP and COO of Saladax Biomedical, Inc. was named one of 12 winners of the EY 2013 class of...

Oct 15, 2013, 16:45 ET

Saladax Receives Florida State Laboratory License

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests that individually optimize a patient's...

Sep 05, 2013, 12:03 ET

Saladax Receives Out-of-State Laboratory Licenses and Approvals to Expand MyCare™ Clinical Laboratory Testing to Clinicians in CA, RI and MD

  Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests that individually optimize a...

Jul 22, 2013, 08:00 ET

Saladax Biomedical Announces Addition to Leadership Team

Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests with the goals of improving health and positively impacting...

Jun 19, 2013, 09:00 ET

Saladax Biomedical Announces U.S. Launch of MyCare™ Portfolio of Chemotherapy Exposure Optimization Tests

 Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests that help physicians to optimize a patient's exposure to...

Jun 10, 2013, 09:01 ET

Saladax Receives CLIA Laboratory Certification and Approval to Begin Clinical Laboratory Operations in Support of MyCare™ Portfolio

 Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests that individually optimize a patient's exposure to...

Apr 18, 2013, 08:30 ET

Saladax Recruits Top Talent as Commercial Introduction of MyCare™ Portfolio of Oncology Diagnostics Nears

 Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Mar 05, 2013, 15:02 ET

Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical

 Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Feb 11, 2013, 10:17 ET

Saladax Biomedical Laboratories to Offer the Full Portfolio of MyCare™ Therapeutic Dose Management Assays in the United States

 Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Dec 06, 2012, 10:17 ET

Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Company's Commercialization Strategy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Nov 16, 2012, 10:17 ET

Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Sep 12, 2012, 10:17 ET

Saladax Biomedical, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York City

Saladax Biomedical, Inc., a commercial-stage, companion diagnostic company with an existing pipeline that enables personalized medicine, announced...

Sep 05, 2012, 10:17 ET

Saladax Biomedical, Inc. Expands Distribution of MyCare™ Products in Israel

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Aug 06, 2012, 10:17 ET

Saladax Biomedical Enters into Master Collaboration Agreement with Bristol-Myers Squibb

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jul 09, 2012, 10:17 ET

Saladax Biomedical, Inc. Extends Availability of its MyCare™ Portfolio in Europe

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jun 15, 2012, 10:17 ET

Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer

 Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Apr 23, 2012, 10:17 ET

Saladax Biomedical, Inc. Expands Distribution of My5-FU in Egypt and Throughout the Middle East North African (MENA) Region

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Mar 12, 2012, 10:17 ET

Saladax Biomedical, Inc. Expands Distribution of My5-FU in Spain and Portugal

 Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of...

Feb 13, 2012, 10:17 ET

CESAR and Saladax Biomedical Collaborate on a Study of Optimized 5-FU Dosing in Colorectal Cancer Patients

 Saladax Biomedical, Inc. and the Central European Society for Anticancer Drug Research (CESAR) announced today they will be collaborating in a...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer